Document Detail


Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
MedLine Citation:
PMID:  19126059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Vitiligo is an acquired, pigmentary skin disorder which is disfiguring and difficult to treat. Phototherapy and application of topical corticosteroids are most commonly prescribed. However, these therapies are often not effective and use of corticosteroids on the face may lead to cutaneous atrophy, telangiectasia, and ocular complications. OBJECTIVE: We sought to assess the efficacy of topical tacrolimus ointment in the treatment of vitiligo. METHODS: A prospective pilot study was performed of 30 patients with vitiligo. Patients were treated with tacrolimus ointment for at least 4 months. Clinical responses were documented during clinic visits, and by pretacrolimus and post-tacrolimus photography. RESULTS: Twenty-five (83.3%) patients showed some repigmentation at the end of 4 months. Patients with vitiligo for more than 5 years also responded well to tacrolimus ointment. Repigmentation in active vitiligo was superior to that in stable vitiligo. 80% of patients with segmental vitiligo of the head and neck showed some response to tacrolimus, but there was no statistical significance between segmental and vulgaris vitiligo. The mean percentage of repigmentation on the head and neck was greater than that on the trunk and extremities. Four patients initially experienced burning on application. CONCLUSIONS: Topical tacrolimus ointment is an effective and well-tolerated alternative therapy for vitiligo especially involving the head and neck.
Authors:
Ai-E Xu; Di-Min Zhang; Xiao-Dong Wei; Bo Huang; Liang-Jun Lu
Related Documents :
19710549 - Topical treatment of psoriasis.
17229609 - Generalized pustular psoriasis (zumbusch): a french epidemiological survey.
6605279 - Plasma steroid levels and clinical effects after topical application of betamethasone.
7092269 - Treatment of pustulosis palmaris et plantaris with oral doses of colchicine.
12567169 - Topical imiquimod 5% cream as an effective treatment for external genital and perianal ...
3307889 - A double-blind study of grenz ray therapy in chronic eczema of the hands.
10893059 - Carotid stents are not a source of microemboli late after deployment.
10556269 - Work disability in an inception cohort of patients with seropositive rheumatoid arthrit...
21149399 - Novel silicone stent to treat tracheobronchial lesions: results of 35 patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  48     ISSN:  1365-4632     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-01-07     Completed Date:  2009-05-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  86-90     Citation Subset:  IM    
Affiliation:
Department of Dermatology, the Third Hospital of Hangzhou, Hangzhou, China. xuaiehz@msn.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adolescent
Adult
Analysis of Variance
Child
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Toxicity
Emollients
Female
Follow-Up Studies
Humans
Immunosuppressive Agents / adverse effects,  therapeutic use*
Male
Pilot Projects
Prospective Studies
Severity of Illness Index
Tacrolimus / adverse effects,  therapeutic use*
Treatment Outcome
Vitiligo / diagnosis,  drug therapy*
Young Adult
Chemical
Reg. No./Substance:
0/Emollients; 0/Immunosuppressive Agents; 109581-93-3/Tacrolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Does tachyphylaxis occur in long-term management of scalp seborrheic dermatitis with pyrithione zinc...
Next Document:  The Tri-focal model of care: advancing the teaching-nursing home concept.